Growth differentiation factor 15 as a biomarker in cardiovascular disease

KC Wollert, T Kempf, L Wallentin - Clinical chemistry, 2017 - academic.oup.com
BACKGROUND Growth differentiation factor 15 (GDF-15) is expressed and secreted in
response to inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene …

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication

A Goette, JM Kalman, L Aguinaga, J Akar… - Heart …, 2017 - heartrhythmjournal.com
The atria provide an important contribution to cardiac function. 1, 2 Besides their impact on
ventricular filling, they serve as a volume reservoir, host pacemaker cells and important parts …

[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

P Kirchhof, S Benussi, D Kotecha… - Polish Heart …, 2016 - journals.viamedica.pl
Komisję ESC ds. Wytycznych Postępowania nadzoruje i koordynuje przygotowywanie
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication

A Goette, JM Kalman, L Aguinaga, J Akar… - Ep …, 2016 - academic.oup.com
The atria provide an important contribution to cardiac function. 1, 2 Besides their impact on
ventricular filling, they serve as a volume reservoir, host pacemaker cells and important parts …

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

Z Hijazi, J Oldgren, J Lindbäck, JH Alexander… - The Lancet, 2016 - thelancet.com
Background The benefit of oral anticoagulation in atrial fibrillation is based on a balance
between reduction in ischaemic stroke and increase in major bleeding. We aimed to …

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

Z Hijazi, J Lindbäck, JH Alexander… - European heart …, 2016 - academic.oup.com
Aims Atrial fibrillation (AF) is associated with an increased risk of stroke, which is currently
estimated by clinical characteristics. The cardiac biomarkers N-terminal fragment B-type …

Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

L Wallentin, J Lindbäck, N Eriksson… - European heart …, 2020 - academic.oup.com
Aims The global COVID-19 pandemic is caused by the SARS-CoV-2 virus entering human
cells using angiotensin-converting enzyme 2 (ACE2) as a cell surface receptor. ACE2 is …

Role of inflammation in atrial fibrillation pathophysiology and management

M Harada, DR Van Wagoner, S Nattel - Circulation journal, 2015 - jstage.jst.go.jp
Atrial fibrillation (AF) is the most common clinically relevant arrhythmia, but the methods
available for treating AF and its complications (of which the most important is …

Atrial myopathy

MJ Shen, R Arora, J Jalife - JACC: Basic to Translational Science, 2019 - jacc.org
This paper discusses the evolving concept of atrial myopathy by presenting how it develops
and how it affects the properties of the atria. It also reviews the complex relationships among …

[HTML][HTML] GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective

R Adela, SK Banerjee - Journal of diabetes research, 2015 - hindawi.com
Growth differentiation factor-15 (GDF-15) is a stress responsive cytokine. It is highly
expressed in cardiomyocytes, adipocytes, macrophages, endothelial cells, and vascular …